When was X-RAY PHOCEA acquired by ESSLING CAPITAL?

X-RAY PHOCEA was acquired by ESSLING CAPITAL in 2023.

What was the revenue of X-RAY PHOCEA at the time of the deal?

The revenue of X-RAY PHOCEA at the time of the deal is estimated to be in the range of €5–25M.

How is the data for the X-RAY PHOCEA acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the X-RAY PHOCEA deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.cic-conseil.eu/fr/telechargements/x-ray-phocea.pdf

What is the average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026?

The average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026 is 14.3x.

← DATABASE

Home Database Healthcare & PharmaX-RAY PHOCEA

12/2023

X-RAY PHOCEA acquired by ESSLING CAPITAL

FRANCE Health Providers / Outpatient Care / Radiology REV €5–25M

Context

X-Ray Phocea, a leading medical imaging group in Southern France, has secured a strategic minority investment from Essling Expansion, alongside Bpifrance and SOFIPACA. Despite this new capital entry, the majority of the group�s shareholding remains in the hands of its 20 associate radiologists, preserving a practitioner-led management model.

X-RAY PHOCEA, which reported an EBITDA margin of [members only] in 2026, is valued in this transaction at an EV/EBITDA multiple of [members only], to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Network of medical imaging centers in the Marseille region.

Ent. Value

€5–25M

Equity Value

[members only]

Multiples

EV / Revenue

[members only]

EV / EBITDA

[members only]

EV / EBIT

[members only]

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2026

2025

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
06/2024	L-GAM / CAPZA / IDIA CAPITAL INVESTISSEMENT	PSV GROUP	FRANCE	Radiology
01/2024	ARDIAN / BPIFRANCE / MACSF	APRIUM PHARMACIE	FRANCE	Pharmacy
12/2023	ANDERA PARTNERS	GROUPE IMAGERIE CARDINET	FRANCE	Radiology
10/2023	EQT PARTNERS	VETPARTNERS	AUSTRALIA	Vet Clinics
08/2023	BAIN CAPITAL	ESTIA HEALTH	AUSTRALIA	Nursing Homes
08/2023	QUADRIVIO GROUP	THE PRIVATE CLINIC (TPC)	UNITED KINGDOM	Aesthetic & Cosmetic Clinics
07/2023	MEDIAN KLINIKEN	HESTIA ALLIANCE	SPAIN	Clinics / Hospitals
06/2023	Levine Leichtman Capital Partners	SEV Laser	UNITED STATES	Aesthetic & Cosmetic Clinics
06/2023	ARDIAN	MON VETO	FRANCE	Vet Clinics
06/2023	PARQUEST CAPITAL	IMANEO	FRANCE	Radiology

REFERENCES

Revenue range: €5–25M

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of X-RAY PHOCEA by ESSLING CAPITAL are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: essling capital